Factor analysis of the Beck Depression Inventory-II with patients with chronic fatigue syndrome.
Brown, Molly, Kaplan, Carly, Jason, Leonard · Journal of health psychology · 2012 · DOI
Quick Summary
This study looked at how well a depression screening tool (the Beck Depression Inventory-II) works for people with ME/CFS. The researchers found that the tool picks up on physical and emotional symptoms separately, and that people with ME/CFS tend to score high on the physical symptom questions because many overlap with ME/CFS symptoms like fatigue. A simpler version of the tool designed for primary care settings worked better for this group.
Why It Matters
Accurate depression screening is important for ME/CFS patients, but standard depression tools may give false readings because ME/CFS physical symptoms (like fatigue and sleep problems) overlap with depression symptoms. This study helps clinicians choose better screening methods and interpret results more accurately, avoiding both missed depression diagnoses and over-diagnosis based on ME/CFS symptoms alone.
Observed Findings
Exploratory factor analysis of BDI-II responses in ME/CFS patients identified two distinct factors: Somatic-Affective and Cognitive
Somatic-Affective factor mean scores were significantly higher than Cognitive factor scores
The BDI-PC (Primary Care version) demonstrated superior validity compared to the full BDI-II in this population
Cognitive factor subscale showed better discriminant validity than the Somatic-Affective factor
Patients with ME/CFS endorse somatic items on the BDI-II at high rates due to symptom overlap with the disease
Inferred Conclusions
Standard BDI-II administration may not accurately assess depression in ME/CFS patients due to symptom overlap, particularly with somatic items
BDI-II factor scores should be evaluated separately rather than relying on total scores for ME/CFS populations
The BDI-PC (Primary Care version) is a more appropriate screening tool for depression in ME/CFS patients
Clinicians should use caution when interpreting elevated somatic symptom endorsement on standard depression scales in ME/CFS populations
Remaining Questions
How do BDI-II results compare between ME/CFS patients with and without comorbid depression to determine diagnostic accuracy?
What This Study Does Not Prove
This study does not prove that depression screening tools cause harm or should never be used with ME/CFS patients. It also does not establish causation between ME/CFS and depression, nor does it determine the actual prevalence of depression in ME/CFS populations—only that standard tools need interpretation adjustments. The findings apply to the specific BDI-II instrument and may not generalize to other depression screening tools.
Tags
Symptom:Fatigue
Method Flag:Weak Case DefinitionNo ControlsSmall Sample